ORANGE, SCOR SE, Another 5 Companies Have A High Estimated Dividend Yield

(VIANEWS) – ORANGE (ORA.PA), SCOR SE (SCR.PA), TINC (TINC.BR) have the highest dividend yield stocks on this list.

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. ORANGE (ORA.PA)

7.3% Foward Dividend Yield

ORANGE’s last close was €11.35, 4.94% under its 52-week high of €11.94. Intraday change was -0.82%.

Orange S.A. provides various fixed telephony and mobile telecommunications, data transmission, and other value-added services to customers, businesses, and other telecommunications operators in France and internationally. The company operates through France; Spain and Other European Countries; The Africa and Middle East; Enterprise; International Carriers & Shared Services; and Mobile Financial Services segments. It offers mobile services, such as voice, SMS, and data; fixed broadband and narrowband services, as well as fixed network business solutions, including voice and data; and convergence packages. The company also sells mobile handsets, broadband equipment, connected devices, and accessories. In addition, it provides IT and integration services comprising unified communication and collaboration services, such as LAN and telephony, consultancy, integration, and project management; hosting and infrastructure services, including cloud computing; customer relations management and other applications services; security services; and video conferencing, as well as sells related equipment. Further, the company offers national and international roaming services; online advertising services; and mobile virtual network operators, network sharing, and mobile financial services, as well as sells equipment to external distributors and brokers. It markets its products and services under the Orange brand. The company was formerly known as France Telecom and changed its name to Orange S.A. in July 2013. Orange S.A. is headquartered in Issy-les-Moulineaux, France.

Earnings Per Share

As for profitability, ORANGE has a trailing twelve months EPS of €0.73.

PE Ratio

ORANGE has a trailing twelve months price to earnings ratio of 15.52. Meaning, the purchaser of the share is investing €15.52 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.44%.

Dividend Yield

According to Morningstar, Inc., the next dividend payment is on Jun 5, 2023, the estimated forward annual dividend rate is 0.8 and the estimated forward annual dividend yield is 7.3%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 2.4%, now sitting on 43.47B for the twelve trailing months.

Sales Growth

ORANGE’s sales growth is 1.7% for the present quarter and 2.5% for the next.

More news about ORANGE.

2. SCOR SE (SCR.PA)

6.7% Foward Dividend Yield

SCOR SE’s last close was €22.75, 22.04% under its 52-week high of €29.18. Intraday change was 0.13%.

SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and Asia Pacific. It operates through two segments, SCOR Global P&C and SCOR Global Life. The SCOR Global P&C segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, agricultural risks, and property catastrophes; specialties insurance products, including business solutions, political and credit risks, cyber, and environmental impairment liability; and business ventures and partnerships. The SCOR Global Life segment provides life reinsurance products, including protection for mortality, morbidity, behavioral risks, disability, long-term care, critical illness, medical, and personal accident. This segment also provides financial solutions that combine traditional life reinsurance with financial components and provide liquidity, balance sheet, solvency, and income improvements to clients; longevity solutions that include products covering the risk of negative deviation from expected results due to the insured or annuitant living longer than assumed in the pricing of insurance covers provided by insurers or pension funds; and distribution solutions. In addition, it is involved in the asset management business. The company was founded in 1970 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, SCOR SE has a trailing twelve months EPS of €-0.95.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.42%.

Volatility

SCOR SE’s last week, last month’s, and last quarter’s current intraday variation average was 1.84%, 0.52%, and 1.91%.

SCOR SE’s highest amplitude of average volatility was 1.84% (last week), 1.55% (last month), and 1.91% (last quarter).

Yearly Top and Bottom Value

SCOR SE’s stock is valued at €22.78 at 07:50 EST, way under its 52-week high of €29.18 and way above its 52-week low of €13.31.

Moving Average

SCOR SE’s value is above its 50-day moving average of €22.23 and way above its 200-day moving average of €19.19.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 315.9% and 205.6%, respectively.

More news about SCOR SE.

3. TINC (TINC.BR)

4.45% Foward Dividend Yield

TINC’s last close was €12.05, 13.68% below its 52-week high of €13.96. Intraday change was 0.41%.

TINC Comm. VA is an investment firm specializing in investments in public and private infrastructure, real assets, and energy sector. TINC Comm. VA is based in Antwerpen, Belgium.

Earnings Per Share

As for profitability, TINC has a trailing twelve months EPS of €0.78.

PE Ratio

TINC has a trailing twelve months price to earnings ratio of 15.51. Meaning, the purchaser of the share is investing €15.51 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.42%.

Yearly Top and Bottom Value

TINC’s stock is valued at €12.10 at 07:50 EST, way under its 52-week high of €13.96 and higher than its 52-week low of €11.96.

Volume

Today’s last reported volume for TINC is 1155 which is 93.82% below its average volume of 18705.

Moving Average

TINC’s worth is below its 50-day moving average of €12.33 and under its 200-day moving average of €12.71.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, TINC’s stock is considered to be overbought (>=80).

More news about TINC.

4. SOLVAY (SOLB.BR)

3.69% Foward Dividend Yield

SOLVAY’s last close was €106.70, 5.53% below its 52-week high of €112.95. Intraday change was 0.33%.

Solvay SA provides advanced materials and specialty chemicals worldwide. It operates through four segments: Materials, Chemicals, Solutions, and Corporate & Business Services. The Materials segment offers specialty polymers, including aromatic polymers, high barrier polymers, and fluoropolymers for the electronics, automotive, aircraft, and healthcare industries; and composite materials for aerospace engineered materials market. The Chemicals segment produces and sells soda ash and sodium bicarbonate primarily to the flat and container glass industries, as well as for use in detergents, pharmaceutical, and feed and food industries; hydrogen peroxide for use primarily in the paper industry to bleach pulp, as well as chemicals, electronics, food, mining, and environment; and dispersible silica for tire manufacturers; and solvent solutions, specialty phenols, polyamide derivatives and smart, functional, and sustainable yarns and polymers. The Solutions segment offers specialty chemicals for agro, home and personal care, coatings, and industrial markets; technology solutions in specialty mining reagents, phosphine-based chemistry, and solutions for the stabilization of polymers; fluorine and rare-earth formulations for automotive, electronics, agrochemical, and construction applications; and vanillin for the flavors and fragrances industries, as well as synthetic intermediates used in pharmaceuticals, agrochemicals, and electronics. This segment also provides friction reducers, gelling agents, emulsion breakers, surfactants, inhibitors, cementing additives, and biocides for upstream oilfield chemicals sector, as well as sodium hypophosphite for metal plating and other applications. The Corporate & Business Services segment provides energy and other business services. The company was founded in 1863 and is headquartered in Brussels, Belgium.

Earnings Per Share

As for profitability, SOLVAY has a trailing twelve months EPS of €18.29.

PE Ratio

SOLVAY has a trailing twelve months price to earnings ratio of 5.85. Meaning, the purchaser of the share is investing €5.85 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.82%.

Sales Growth

SOLVAY’s sales growth is 6.6% for the present quarter and negative 4.7% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SOLVAY’s stock is considered to be oversold (<=20).

More news about SOLVAY.

5. SANOFI (SAN.PA)

3.55% Foward Dividend Yield

SANOFI’s last close was €101.84, 4.52% below its 52-week high of €106.66. Intraday change was -0.16%.

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, SANOFI has a trailing twelve months EPS of €6.66.

PE Ratio

SANOFI has a trailing twelve months price to earnings ratio of 15.27. Meaning, the purchaser of the share is investing €15.27 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.77%.

Volatility

SANOFI’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.30%, a positive 0.64%, and a positive 0.87%.

SANOFI’s highest amplitude of average volatility was 0.63% (last week), 1.14% (last month), and 0.87% (last quarter).

More news about SANOFI.

6. SHURGARD (SHUR.BR)

2.73% Foward Dividend Yield

SHURGARD’s last close was €47.69, 19.71% under its 52-week high of €59.40. Intraday change was -1.78%.

Shurgard Self Storage Ltd, together with its subsidiaries, engages in the acquisition, development, and operation of self-storage facilities for business and personal use. The company also offers various ancillary services at its self-storage facilities consisting of sale of storage products and provision of protection through an independent insurance company for customers' stored goods. The company owns and/or operates 267 self-storage facilities and approximately 1.4 million net rentable square meters in France, the Netherlands, the United Kingdom, Sweden, Germany, Belgium, and Denmark. Shurgard Self Storage Ltd was founded in 1995 and is based in Luxembourg, Luxembourg.

Earnings Per Share

As for profitability, SHURGARD has a trailing twelve months EPS of €7.45.

PE Ratio

SHURGARD has a trailing twelve months price to earnings ratio of 6.29. Meaning, the purchaser of the share is investing €6.29 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.54%.

Moving Average

SHURGARD’s worth is above its 50-day moving average of €45.66 and above its 200-day moving average of €45.20.

Sales Growth

SHURGARD’s sales growth is 4.2% for the current quarter and 2.4% for the next.

More news about SHURGARD.

7. CEGEDIM (CGM.PA)

2.63% Foward Dividend Yield

CEGEDIM’s last close was €19.00, 24.45% below its 52-week high of €25.15. Intraday change was -0.42%.

Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide. It operates in two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals. This division also provides solutions for hosting, HR and payroll management outsourcing, and electronic data exchange services. The Healthcare Professionals division offers management software, databases, and solutions to doctors, allied health professionals, pharmacists, and healthcare facilities. The company was incorporated in 1969 and is headquartered in Boulogne-Billancourt, France. Cegedim SA is a subsidiary of FCB SA.

Earnings Per Share

As for profitability, CEGEDIM has a trailing twelve months EPS of €1.01.

PE Ratio

CEGEDIM has a trailing twelve months price to earnings ratio of 18.71. Meaning, the purchaser of the share is investing €18.71 for every euro of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.08%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, CEGEDIM’s stock is considered to be overbought (>=80).

More news about CEGEDIM.